David Grdina to Humans
This is a "connection" page, showing publications David Grdina has written about Humans.
Connection Strength
0.292
-
ROS modifiers and NOX4 affect the expression of the survivin-associated radio-adaptive response. Free Radic Biol Med. 2018 08 01; 123:39-52.
Score: 0.021
-
TP53 Mutational Status and ROS Effect the Expression of the Survivin-Associated Radio-Adaptive Response. Radiat Res. 2017 11; 188(5):579-590.
Score: 0.020
-
Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugs. Radiat Res. 2014 May; 181(5):464-70.
Score: 0.016
-
A survivin-associated adaptive response in radiation therapy. Cancer Res. 2013 Jul 15; 73(14):4418-28.
Score: 0.015
-
A manganese superoxide dismutase (SOD2)-mediated adaptive response. Radiat Res. 2013 Feb; 179(2):115-24.
Score: 0.015
-
SOD2-mediated effects induced by WR1065 and low-dose ionizing radiation on micronucleus formation in RKO human colon carcinoma cells. Radiat Res. 2011 Jan; 175(1):57-65.
Score: 0.013
-
Maintenance of manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by repeated administration of the free thiol form of amifostine. Radiat Res. 2008 May; 169(5):495-505.
Score: 0.011
-
Relationship between phosphorylated histone H2AX formation and cell survival in human microvascular endothelial cells (HMEC) as a function of ionizing radiation exposure in the presence or absence of thiol-containing drugs. Radiat Res. 2007 Jul; 168(1):106-14.
Score: 0.010
-
Manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by the free thiol form of amifostine and tumor necrosis factor alpha. Radiat Res. 2007 Apr; 167(4):465-74.
Score: 0.010
-
Flow cytometric analysis of phosphorylated histone H2AX following exposure to ionizing radiation in human microvascular endothelial cells. J Radiat Res. 2006 Nov; 47(3-4):245-57.
Score: 0.010
-
Delayed radioprotection by nuclear transcription factor kappaB -mediated induction of manganese superoxide dismutase in human microvascular endothelial cells after exposure to the free radical scavenger WR1065. Free Radic Biol Med. 2006 Mar 15; 40(6):1004-16.
Score: 0.009
-
Radioprotectors: current status and new directions. Radiat Res. 2005 Jun; 163(6):704-5.
Score: 0.009
-
Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC). Int J Radiat Oncol Biol Phys. 2004 Oct 01; 60(2):553-63.
Score: 0.008
-
Activation of the nuclear transcription factor kappaB (NFkappaB) and differential gene expression in U87 glioma cells after exposure to the cytoprotector amifostine. Int J Radiat Oncol Biol Phys. 2002 May 01; 53(1):180-9.
Score: 0.007
-
Relationships between cytoprotection and mutation prevention by WR-1065. Mil Med. 2002 Feb; 167(2 Suppl):51-3.
Score: 0.007
-
Differential activation of nuclear transcription factor kappaB, gene expression, and proteins by amifostine's free thiol in human microvascular endothelial and glioma cells. Semin Radiat Oncol. 2002 Jan; 12(1 Suppl 1):103-11.
Score: 0.007
-
Radioprotectants: current status and new directions. Oncology. 2002; 63 Suppl 2:2-10.
Score: 0.007
-
Activation of NFkappaB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells. Free Radic Biol Med. 2001 Jun 15; 30(12):1426-39.
Score: 0.007
-
Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells. Nat Commun. 2020 09 14; 11(1):4591.
Score: 0.006
-
Cytoprotection by WR-1065, the active form of amifostine, is independent of p53 status in human malignant glioma cell lines. Int J Radiat Biol. 2000 May; 76(5):633-9.
Score: 0.006
-
Amifostine: mechanisms of action underlying cytoprotection and chemoprevention. Drug Metabol Drug Interact. 2000; 16(4):237-79.
Score: 0.006
-
Antimutagenic effects of amifostine: clinical implications. Semin Oncol. 1996 Aug; 23(4 Suppl 8):53-7.
Score: 0.005
-
The Increase in Animal Mortality Risk following Exposure to Sparsely Ionizing Radiation Is Not Linear Quadratic with Dose. PLoS One. 2015; 10(12):e0140989.
Score: 0.005
-
CDK1 Enhances Mitochondrial Bioenergetics for Radiation-Induced DNA Repair. Cell Rep. 2015 Dec 15; 13(10):2056-63.
Score: 0.005
-
CDK4-mediated MnSOD activation and mitochondrial homeostasis in radioadaptive protection. Free Radic Biol Med. 2015 Apr; 81:77-87.
Score: 0.004
-
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nat Genet. 2013 Dec; 45(12):1439-45.
Score: 0.004
-
CyclinB1/Cdk1 phosphorylates mitochondrial antioxidant MnSOD in cell adaptive response to radiation stress. J Mol Cell Biol. 2013 Jun; 5(3):166-75.
Score: 0.004
-
Manganese superoxide dismutase interacts with a large scale of cellular and mitochondrial proteins in low-dose radiation-induced adaptive radioprotection. Free Radic Biol Med. 2012 Nov 15; 53(10):1838-47.
Score: 0.004
-
Protection against AZT-induced mutagenesis at the HGPRT locus in a human cell line by WR-151326. Int J Radiat Oncol Biol Phys. 1992; 22(4):813-5.
Score: 0.003
-
Analysis of ascites from patients with ovarian carcinoma by cell flow cytometry. Gynecol Oncol. 1992 Jan; 44(1):10-2.
Score: 0.003
-
Variation in radiation sensitivity during the cell cycle of two human squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 1991 Apr; 20(4):733-8.
Score: 0.003
-
Amifostine metabolite WR-1065 disrupts homologous recombination in mammalian cells. Radiat Res. 2010 Feb; 173(2):175-83.
Score: 0.003
-
Coactivation of ATM/ERK/NF-kappaB in the low-dose radiation-induced radioadaptive response in human skin keratinocytes. Free Radic Biol Med. 2009 Jun 01; 46(11):1543-50.
Score: 0.003
-
Radiation protectors: the unexpected benefits. Drug Metab Rev. 1989; 20(1):13-42.
Score: 0.003
-
WR-1065, the active metabolite of amifostine, mitigates radiation-induced delayed genomic instability. Free Radic Biol Med. 2008 Dec 15; 45(12):1674-81.
Score: 0.003
-
Radioprotectors in treatment therapy to reduce risk in secondary tumor induction. Pharmacol Ther. 1988; 39(1-3):21-5.
Score: 0.003
-
Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003. Radiat Res. 2004 Dec; 162(6):711-28.
Score: 0.002
-
Method of RNA purification from endothelial cells for DNA array experiments. Biotechniques. 2002 Feb; 32(2):316, 318, 320.
Score: 0.002
-
Radiosensitivity of mammalian cell lines engineered to overexpress cytosolic glutathione peroxidase. Radiat Res. 2001 Apr; 155(4):536-42.
Score: 0.002
-
Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity. Cancer Res. 1999 Jul 01; 59(13):3059-63.
Score: 0.001
-
Attenuation of G2-phase cell cycle checkpoint control is associated with increased frequencies of unrejoined chromosome breaks in human tumor cells. Radiat Res. 1996 Aug; 146(2):139-43.
Score: 0.001
-
Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetry. Radiat Res. 1996 May; 145(5):610-8.
Score: 0.001
-
Transformation of human epidermal keratinocytes with fission neutrons. Carcinogenesis. 1994 Dec; 15(12):2867-73.
Score: 0.001
-
The role of intracellular calcium in the cellular response to ionizing radiation. Radiat Res. 1994 Jun; 138(3):392-400.
Score: 0.001
-
Buoyant density separation of human blood cells in renografin gradients. Exp Cell Res. 1973 Sep; 81(1):250-4.
Score: 0.001
-
The effect of topoisomerase inhibitors on the expression of differentiation markers and cell cycle progression in human K-562 leukemia cells. Exp Cell Res. 1992 Nov; 203(1):100-6.
Score: 0.001
-
The isoquinoline sulfonamide H7 attenuates radiation-mediated protein kinase C activation and delays the onset of x-ray-induced G2 arrest. Int J Radiat Oncol Biol Phys. 1992; 24(4):687-92.
Score: 0.001
-
Radiation-induced DNA double-strand break frequencies in human squamous cell carcinoma cell lines of different radiation sensitivities. Int J Radiat Biol. 1991 Jun; 59(6):1341-52.
Score: 0.001
-
Analysis of free radical damage within single cells using flow cytometry. Mol Aspects Med. 1991; 12(2):129-35.
Score: 0.001
-
The inherent cellular radiosensitivity of epithelial ovarian carcinoma. Gynecol Oncol. 1989 Dec; 35(3):282-5.
Score: 0.001
-
Characterization of a human ovarian carcinoma. Anal Quant Cytol Histol. 1989 Oct; 11(5):324-30.
Score: 0.001
-
The development of alpha-emitting radionuclide lead 212 for the potential treatment of ovarian carcinoma. Am J Obstet Gynecol. 1989 Apr; 160(4):789-97.
Score: 0.001
-
The effect of the alpha-emitting radionuclide lead-212 on human ovarian carcinoma: a potential new form of therapy. Gynecol Oncol. 1989 Feb; 32(2):236-9.
Score: 0.001